{
    "nctId": "NCT02127073",
    "briefTitle": "Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer",
    "officialTitle": "Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Ductal Carcinoma in Situ",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 8,
    "primaryOutcomeMeasure": "Percentage of Patients With Detection of microRNA in NAF, Serum, or Tissue",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of Ductal carcinoma in situ (DCIS) or invasive breast cancer\n* Candidate for breast conserving surgery or mastectomy\n\nExclusion Criteria:\n\n* Pregnant women\n* Prior Breast Cancer diagnosis\n* Adverse reaction to Oxytocin in the past",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}